Skip to main content
Caplight Logo









A4Cell

A4Cell

Private
MadridHealthcare & Life Scienceshttps://a4cell.com/

Last Round

Series B

Nov 16, 2023

Total Funding Raised

$5.51M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

A4Cell is a biotechnology company that develops intracellular silicon microchips, known as SPAchips, for real-time monitoring of living single-cell physiology in drug discovery and research applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

single-cell analysisintracellular sensorslive-cell imagingdrug discoverynanotechnologycell biologytoxicologymicrochip technologylab-on-a-chipcellular monitoringassay kitshigh-content screeningHCSpersonalized medicinebio-sensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

A4Cell Comparables

Compare A4Cell with similar companies based on industry and business-model similarity.

A4Cell comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axion BioSystems
77%
Saguaro Biosciences
75%
Sartorius Aktiengesellschaft
70%

A4Cell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 16, 2023
Series ADec 27, 2021
Pre SeedFeb 1, 2018

Key People

Founding team and executive leadership

Elena Rivas

Principal Chief Executive Officer

Executive Team

A4Cell Investors

Notable investors and investment history

A4Cell investors
InvestorRounds
Dreavent CapitalSeries B
CDTI InnvierteSeries B
BeAble CapitalSeries B, Seed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 321% MoM, from 419 to 1.8K.

  • Apr 5, 2026

    Monthly visitors grew 108% MoM, reaching 1.4K.

A4Cell Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

A4Cell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about A4Cell's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadrid
Employee Range4
Year Founded2018
Last FundingNov 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?